Plantibodies Signs Sponsored Research Agreement with Nasdaq-Listed Biotech to Advance Oral Biologics for Rare GI Diseases
Paris, France — September 25th, 2025 — Plantibodies, a French biotech company pioneering oral delivery of biologics through plant-based bioencapsulation, today announced a […]